Skip to main content
SpringerLink
Log in

Perturbations hormonales, fertilité et contraception aprés le traitement d’un cancer

  • Chapter
Aider á vivre aprés un cancer

Part of the book series: Oncologie pratique ((ONCOLPRAT))

  • 395 Accesses

Résumé

Le cancer est la deuxiéme cause de décés chez les femmes de moins de 40 ans dans les pays occidentaux. Les cancers les plus fréquents, chez les femmes entre 20 et 40 ans, sont le cancer de sein, le cancer du col de l’utérus et les leucémies (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Jemal A, Siegel R, Ward E, et al. (2006) Cancer statistics. CA Cancer J Clin 56: 106–30

    Article  PubMed  Google Scholar 

  2. Lee SJ, Schover LR, Partridge AH, et al. (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24: 2917–31

    Article  PubMed  Google Scholar 

  3. Benjamin I, Morgan MA, Rubin SC (1999) Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 72: 288–91

    Article  PubMed  CAS  Google Scholar 

  4. Critchley HO and Wallace WH (2005) Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 34: 64–8

    Article  PubMed  Google Scholar 

  5. Meirow D and Nugent D (2001) The effect of radiotherapy and chemotherapy on female reproduction. Human Reprod Update 7: 535–43

    Article  CAS  Google Scholar 

  6. Chiarelli AM, Marrett LD, Darlington G (1999) Early menopause and infertility in females after treatment of childhood cancer diagnosed in 1964–1988 in Ontario, Canada. Am J Epidemiol 150: 245–54

    Article  PubMed  CAS  Google Scholar 

  7. Larsen EC, Müller J, Schmiegelow K, et al. (2003) Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88: 5307–14

    Article  PubMed  CAS  Google Scholar 

  8. Bath LE, Wallace WH, Shaw MP, et al. (2003) Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18: 2368–74

    Article  PubMed  CAS  Google Scholar 

  9. Sklar CA, Mertens AC, Mitby P, et al. (2006) Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Nat Clin Invest 98: 890–6

    Google Scholar 

  10. Jones AL (2006) Fertility and pregnancy after breast cancer. Breast 15 Suppl 2: S41–6

    Article  Google Scholar 

  11. Elis A, Tevet A, Yerushalmi R, et al. (2006) Fertility status among women treated for aggressive non-Hodgkin’s lymphoma. Leuk Lymphoma 47: 623–7

    Article  PubMed  Google Scholar 

  12. Franchi-Rezgui P, Rousselot P, Espie M, et al. (2003) Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 4: 116–20

    Article  PubMed  CAS  Google Scholar 

  13. Faddy MJ, Gosden RG, Gougeon A, et al. (1992) Accelerated disappearance of ovarian follicles in the mid-life: implications for forecasting menopause. Hum Reprod 7: 1342–6

    PubMed  CAS  Google Scholar 

  14. Haie-Meder C, Mlika-Cabanne N, Michel G, et al. (1993) Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiol Oncol Biol Physics 25: 419–24

    Article  CAS  Google Scholar 

  15. Bath LE, Critchley HO, Chambers SE, et al. (1999) Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol 106: 1265–72

    Article  PubMed  CAS  Google Scholar 

  16. Holm K, Nysom K, Brocks V, et al. (1999) Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogenic bone marrow transplantation. Bone Marrow Transplant 23: 359–63

    Article  Google Scholar 

  17. Creus M, Peñarrubia J, Fábregues F, et al. (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15: 2341–6

    Article  PubMed  CAS  Google Scholar 

  18. Weenen C, Laven JS, Von Bergh AR, et al. (2004) Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10: 77–83

    Article  PubMed  CAS  Google Scholar 

  19. Fanchin R, Taieb J, Lozano DH, et al. (2005) High reproducibility of serum anti-mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20: 923–7

    Article  PubMed  CAS  Google Scholar 

  20. Haie-Meder C, Morice P, Paris B, et al. (2004) Consequences of brachytherapy on uterine myocontractility. Radiother Oncol suppl 71: S54.

    Google Scholar 

  21. Morice P, Juncker L, Rey A, et al. (2000) Ovarian transposition for patients with cervical carcinoma treated by radio-surgical combination. Fertil Steril 74: 743–8

    Article  PubMed  CAS  Google Scholar 

  22. Yamamoto R, Okamoto K, Yukiharu T, et al. (2001) A study of risk factor for ovarian metastases in stage IB–IIB cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol 82: 312–6

    Article  PubMed  CAS  Google Scholar 

  23. Morice P (2006) Borderline tumor of the ovary and fertility. Eur J Cancer 42: 149–58

    Article  PubMed  CAS  Google Scholar 

  24. Basille C, Olivennes F, Le Calvez J, et al. (2006) Impact of gonadotropins and steroid hormones on borderline ovarian cells. Hum Reprod 21: 3241–5

    Article  PubMed  CAS  Google Scholar 

  25. Fortin A, Morice P, Thoury A, et al. (2007) Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril 87: 591–6

    Article  PubMed  Google Scholar 

  26. Morice P, Leblanc E, Rey A, et al. (2005) Conservative treatment of epithelial ovarian Cancer: Results of a french multicenter study of the GCCLCC (Groupe des Chirurgiens de Centres de Lutte Contre le Cancer) and SFOG (Société Française d’Oncologie Gynécologique). Human Reprod 20: 1379–85

    Article  CAS  Google Scholar 

  27. Chopin N, et al. (2006) Radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy: An international series. Int J Gynecol Cancer 16 (suppl 3): 602

    Google Scholar 

  28. Roberts JE and Oktay K (2005) Fertility preservation: a comprehensive approach to the young woman with cancer. J Natl Cancer Inst Monogr 34: 57–9

    Article  PubMed  Google Scholar 

  29. Blumenfeld Z, Eckman A (2005) Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr 34: 40–3

    Article  PubMed  CAS  Google Scholar 

  30. Pereyra Pacheco B, Méndez Ribas JM, Milone G, et al. (2001) Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 81: 391–7

    Article  PubMed  CAS  Google Scholar 

  31. Lobo R (2005) Potential options for preservation of fertility in women. N Engl J Med 353: 64–73

    Article  PubMed  CAS  Google Scholar 

  32. Oktay K, Hourvitz A, Sahin G, et al. (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. JCEM 91: 3885–90

    PubMed  CAS  Google Scholar 

  33. Lassalle B, Testart J, Renard JP (1985) Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol. Fertil Steril 44: 645–51

    PubMed  CAS  Google Scholar 

  34. Cohen J, Simons RF, Edwards RG, et al. (1985) Pregnancies following the frozen storage of expanding human blastocysts. J In Vitro Fert Embryo Transf 2: 59–64

    Article  PubMed  CAS  Google Scholar 

  35. Stehlik E, Stehlik J, Katayama KP, et al. (2005) Vitrification demonstrates significant improvement versus slow freezing of human blastocysts. Reprod Biomed Online 11: 53–7

    Article  PubMed  Google Scholar 

  36. Chen SU, Lien YR, Chen HF et al. (2005) Observational clinical follow-up of oocyte cryopreservation using a slow-freezing method with 1,2-propanediol plus sucrose followed with ICSI. Hum Reprod 20: 1975–80

    Article  PubMed  CAS  Google Scholar 

  37. Porcu E, Fabbri R, Damiano G et al. (2000) Clinical experience and applications of oocyte cryopreservation. Mol Cell Endocrinol 169: 33–7

    Article  PubMed  CAS  Google Scholar 

  38. Yoon TK, Kim TJ, Park SE, et al. (2003) Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril 79: 1323–6

    Article  PubMed  Google Scholar 

  39. Callejo J, Salvador C, Miralles A, et al. (2001) Long-term ovarian function evaluation after autografting by transplantation with fresh and frozen-thawed human ovarian tissue. J Clin Endocrinol Metab 86: 4489–94

    Article  PubMed  CAS  Google Scholar 

  40. Oktay K, Buyuk E, Veeck L, et al. (2004) Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363: 837–40

    Article  PubMed  Google Scholar 

  41. Donnez J, Dolmans MM, Demylle D, et al. (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: 1405–10

    Article  PubMed  CAS  Google Scholar 

  42. Meirow D, Levron J, Eldar-Geva T, et al. (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in patient with ovarian failure after chemotherapy. N Engl J Med 353: 318–21

    Article  PubMed  CAS  Google Scholar 

  43. Demeestere I, Simon P, Emiliani S, et al. (2007) Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 12(12): 1437–42

    Article  PubMed  Google Scholar 

  44. Lushbaugh CC, Casarett GW (1976) The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer 37 (2 Suppl): 1111–25

    Article  PubMed  CAS  Google Scholar 

  45. Stillman RJ, Schinfeld JS, Schiff I, et al. (1981) Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 139(1): 62–6

    PubMed  CAS  Google Scholar 

  46. Fisher B, Cheung AY (1984) Delayed effect of radiation therapy with or without chemotherapy on ovarian function in women with Hodgkin’s disease. Acta Radiol Oncol 23: 43–8

    Article  PubMed  CAS  Google Scholar 

  47. Santoro A, Bredenfeld H, Devizzi L, et al. (2000) Gemcitabine in the treatment of refractory Hodgkin’s disease: results of a multicenter phase II study. J Clin Oncol 18: 2615–9

    PubMed  CAS  Google Scholar 

  48. Brusamolino E, Lunghi F, Orlandi E, et al. (2000) Treatment of early-stage Hodgkin’s disease with four cycles of ABVD followed by adjuvant radiotherapy: analysis of efficacy and long-term toxicity. Hematologica 85(10): 1032–9

    CAS  Google Scholar 

  49. Lower EE, Blau R, Gazder P, Tummala R (1999) The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med 8(7): 949–54

    Article  PubMed  CAS  Google Scholar 

  50. Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14(5): 1718–29

    PubMed  CAS  Google Scholar 

  51. Reh A, Oktem O, Oktay K (2007) Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril Dec 29 [Epub ahead of print].

    Google Scholar 

  52. Gershenson DM (1988) Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 6(2): 270–5

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’histologie-embryologie-cytogénétique CECOS-Assistance publique, Hôpitaux de Paris CHU Jean-Verdier, 93140, Bondy

    Rachel Lévy & M. Filali

  2. Service d’histologie-embryologie-cytogénétique et génétique de la reproductin, Hôpital Antoine-Béclére, 92140, Clamart

    Nelly Frydman & Nadia Prisant

  3. Institut Gustave-Roussy, Université Paris-Sud, 39, rue Camille Desmoulins, 94805, Villejuif

    Philippe Morice

Authors
  1. Rachel Lévy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nelly Frydman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Filali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nadia Prisant
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Philippe Morice
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France

About this chapter

Cite this chapter

Lévy, R., Frydman, N., Filali, M., Prisant, N., Morice, P. (2010). Perturbations hormonales, fertilité et contraception aprés le traitement d’un cancer. In: Aider á vivre aprés un cancer. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-79501-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-79501-5_7

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-79500-8

  • Online ISBN: 978-2-287-79501-5

Publish with us

Policies and ethics

Search

Navigation